| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/13/2015 | US8932498 Device for preparation of liposomes and method thereof |
| 01/13/2015 | US8932253 Medication infusion device using negatively biased ambient pressure medication chamber |
| 01/13/2015 | US8931490 Systems and methods for nanomagnetic actuation of molecular cell signaling |
| 01/13/2015 | CA2827225C Apparatus for the controlled release of topical nitric oxide |
| 01/13/2015 | CA2747395C Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives |
| 01/13/2015 | CA2741041C Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivative |
| 01/13/2015 | CA2741038C Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate |
| 01/13/2015 | CA2682200C Transdermal patch and method for delivery of vitamin b12 |
| 01/13/2015 | CA2676981C Powders for reconstitution |
| 01/13/2015 | CA2645142C Regulating stem cells |
| 01/13/2015 | CA2630248C Machine and method for pharmaceutical and pharmaceutical-like product assembly |
| 01/13/2015 | CA2623429C Interleukin-13 antibody composition |
| 01/13/2015 | CA2622342C Processing of chitosan and chitosan derivatives |
| 01/13/2015 | CA2609000C An implantable therapy system for treating a living being with an active factor |
| 01/13/2015 | CA2598204C Stabilized hme composition with small drug particles |
| 01/13/2015 | CA2596759C Local treatment of neurofibromas |
| 01/10/2015 | CA2856332A1 Method for producing a tissue paper sheet material containing an adjuvant substance for the treatment of allergic rhinitis, and the product obtained |
| 01/08/2015 | WO2015003140A1 Method of making water soluble injectable calcium polyphosphate gels |
| 01/08/2015 | WO2015003109A1 Capsule formulation comprising fexofenadine |
| 01/08/2015 | WO2015002804A1 Liquid titanium fabric |
| 01/08/2015 | WO2015002574A1 Method for producing bio-gel and a bio-gel |
| 01/08/2015 | WO2015002378A1 Pharmaceutical composition for promoting bone tissue formation, containing stauntonia hexaphylla leaf extract as active ingredient |
| 01/08/2015 | WO2015002091A1 Water-soluble hyaluronic acid gel and method for producing same |
| 01/08/2015 | WO2015002078A1 Novel boronic acid compound preparation |
| 01/08/2015 | WO2015001995A1 Rocuronium preparation with improved vascular pain, method for producing same, and method for suppressing and relieving vascular pain using same |
| 01/08/2015 | WO2015001569A1 A solid pharmaceutical composition of ivabradine for oral administration |
| 01/08/2015 | WO2015001564A1 Low friction hydrogels and hydrogel-containing composite materials |
| 01/08/2015 | WO2015001541A2 Pharmaceutical film composition |
| 01/08/2015 | WO2015001489A1 Pharmaceutical compositions of ticagrelor |
| 01/08/2015 | WO2015001488A1 Extended-release tablets of paliperidone and processes of preparation thereof |
| 01/08/2015 | WO2015001478A1 Liquid pharmaceutical composition for oral administration comprising fexofenadine |
| 01/08/2015 | WO2015001379A1 Tauroursodeoxycholic acid (tudca) for use in the treatment of neurodegenerative disorders |
| 01/08/2015 | WO2015001349A1 Methods and compounds for preventing osteoarthritis |
| 01/08/2015 | WO2015001329A1 Chewable tablet |
| 01/08/2015 | WO2015001160A1 Lipid nanoparticle of polymyxin |
| 01/08/2015 | WO2015001087A2 Drug-delivery composition for topical applications and injections and ophtalmic formulations, method for manufacturing thereof, and methods for delivery a drug-delivery composition |
| 01/08/2015 | WO2015001012A1 Transdermal therapeutic system with electronic component |
| 01/08/2015 | WO2015000853A1 Pharmaceutical composition comprising a solid dispersion of tadalafil |
| 01/08/2015 | WO2015000831A1 Method for preparing virosomes |
| 01/08/2015 | WO2015000371A1 He pula peptide formulation |
| 01/08/2015 | WO2014023421A9 Liposome composition for use in peritoneal dialysis |
| 01/08/2015 | WO2013169979A9 Polymorph compositions, methods of making, and uses thereof |
| 01/08/2015 | US20150011937 Constant rate fluid delivery device with selectable flow rate and titratable bolus button |
| 01/08/2015 | US20150011655 Flow system method for preparing substantially pure nanoparticles, nanoparticles obtained by this method and use thereof |
| 01/08/2015 | US20150011653 Novel Microbial Pathogen inhibitor |
| 01/08/2015 | US20150011641 High load dispersions |
| 01/08/2015 | US20150011638 Alprostadil and lidocaine treatment of premature ejaculation |
| 01/08/2015 | US20150011635 Diclofenac topical formulation |
| 01/08/2015 | US20150011634 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 01/08/2015 | US20150011626 Methods of treating and preventing diseases and disorders of the central nervous system |
| 01/08/2015 | US20150011612 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF |
| 01/08/2015 | US20150011608 iRNA Agents Targeting VEGF |
| 01/08/2015 | US20150011596 Topical localized isoxazoline formulation comprising glycofurol |
| 01/08/2015 | US20150011588 Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| 01/08/2015 | US20150011587 Alprostadil for treatment of premature ejaculation |
| 01/08/2015 | US20150011585 Alprostadil and dyclonine for treatment of premature ejaculation |
| 01/08/2015 | US20150011578 Methods for improving muscle strength |
| 01/08/2015 | US20150011577 Oxymorphone controlled release formulations |
| 01/08/2015 | US20150011570 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 01/08/2015 | US20150011525 Solid dispersion of poorly soluble compounds comprising crospovidone and at least one water-soluble polymer |
| 01/08/2015 | US20150011520 Pharmaceutical compositions to reduce complications of ocular steroid |
| 01/08/2015 | US20150011518 Non-aqueous liquid composition |
| 01/08/2015 | US20150011515 Hormone Containing Emulsion |
| 01/08/2015 | US20150011514 Celecoxib Compositions |
| 01/08/2015 | US20150011507 Compositions comprising lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 01/08/2015 | US20150011489 Treatment of inflammatory lesions of rosacea with ivermectin |
| 01/08/2015 | US20150011475 Method for screening an agent being useful for the treatment of dry eye and /or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method |
| 01/08/2015 | US20150011472 Malleable multi-component implants and materials therefor |
| 01/08/2015 | US20150010758 Tablet, method of producing tablet, tablet management device, tablet verification device and program storage medium |
| 01/08/2015 | US20150010663 Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
| 01/08/2015 | US20150010662 Cancer treatments and compositions for use thereof |
| 01/08/2015 | US20150010661 Techniques and systems for treatment of neuropathic pain and other indications |
| 01/08/2015 | US20150010659 Methods and compositions for muscular and neuromuscular diseases |
| 01/08/2015 | US20150010657 Methods and systems for treatment of inflammatory diseases with nitric oxide |
| 01/08/2015 | US20150010655 Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
| 01/08/2015 | US20150010650 Compositions comprising biomembrane sealing agent for treatment of pain or inflammation, and methods of use |
| 01/08/2015 | US20150010642 Composition of a bone repair mixture |
| 01/08/2015 | US20150010641 Micro-, submicro- and nano-structures containing amaranth protein |
| 01/08/2015 | US20150010639 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders |
| 01/08/2015 | US20150010638 Method for Improving Water Solubility of Slightly Soluble Substance |
| 01/08/2015 | US20150010637 Aqueous Suspensions of TMC278 |
| 01/08/2015 | US20150010636 Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions |
| 01/08/2015 | US20150010634 Prevention and treatment of ocular conditions |
| 01/08/2015 | US20150010633 Novel aerosol formulations of ondansetron and uses thereof |
| 01/08/2015 | US20150010632 Novel aerosol formulations of granisetron and uses thereof |
| 01/08/2015 | US20150010631 Immune-modifying nanoparticles for the treatment of inflammatory diseases |
| 01/08/2015 | US20150010629 Controlled release and taste masking oral pharmaceutical composition |
| 01/08/2015 | US20150010628 Pharmaceutical composition and administrations thereof |
| 01/08/2015 | US20150010627 New pharmaceutical compositions of flurbiprofen and glucosamin |
| 01/08/2015 | US20150010626 Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity |
| 01/08/2015 | US20150010624 Carbidopa/lipodopa gastroretentive drug delivery |
| 01/08/2015 | US20150010623 Controlled release preparations |
| 01/08/2015 | US20150010622 Capsule formulation comprising fexofenadine |
| 01/08/2015 | US20150010621 Sustained release solid dosage preparations |
| 01/08/2015 | US20150010620 Bulk Enteric Capsule Shells |
| 01/08/2015 | US20150010619 Methods and systems for treatment of migraines and other indications |
| 01/08/2015 | US20150010617 Inhalable liquid formulations of dnase i |
| 01/08/2015 | US20150010616 Biocompatible Particles and Method for Preparing Same |
| 01/08/2015 | US20150010614 Methods and use of inducing apoptosis in cancer cells |
| 01/08/2015 | US20150010613 Compositions and methods for cancer immunotherapy |